<Anchor>
Some European countries have temporarily stopped vaccination due to adverse events after vaccination.
However, he explained that there is no association with the vaccine yet, and it is a preventive investigation measure.
This is Jung Hye-kyung.
<Reporter>
Health authorities in Denmark, Norway, Italy and Iceland have said they are temporarily suspending the use of the AstraZeneca vaccine.
On the 11th of local time, Reuters reported that a 60-year-old woman in Denmark also developed a blood clot and died after getting the AstraZeneca vaccine.
Danish authorities believe the woman has received the same manufacturing unit vaccine as a woman who previously died of similar symptoms in Austria.
The manufacturing unit vaccine has so far been supplied to 17 European countries.
However, countries that have decided to discontinue use said it could not be concluded on the link between the vaccine and blood clots as a prophylactic measure for investigation.
The European Medicines Agency reaffirmed its confidence in the vaccine, saying, "The efficacy of vaccination is much higher than the risk," in a statement by member countries to discontinue use of the vaccine.
Other countries, such as the UK, also emphasized that there was no evidence of adverse reactions, and said they would not change the existing recommendations.
[Dominique Raab/ British Foreign Minister: AstraZeneca is aware of the situation.
The UK has all been tested and is very confident about the safety of the vaccine.]
Meanwhile, the European Union has officially approved the use of a vaccine developed by the US pharmaceutical company Johnson & Johnson.
This has increased the number of vaccines available within the European Union to four.